Pavel Kibrik
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Pavel Kibrik has a total of 109 co-authors. Here are the top co-authors by number of shared publications:
Enrico Ascher
21 shared publications- Anil Hingorani
Division of Vascular Surgery, NYU Langone Hospital-Brooklyn, Brooklyn, NY
18 shared publications Natalie Marks
Total Vascular Care, NYU Langone Health, Brooklyn, NY, USA
15 shared publications- Ahmad Alsheekh
Vascular Institute of New York, Brooklyn, NY, USA
12 shared publications - Jesse Chait
Division of Vascular and Endovascular Surgery, Mayo Clinic, Rochester, MN, USA
12 shared publications Anil Hingorani
Vascular Institute of New York and the Division of Vascular Surgery, NYU Langone Brooklyn
8 shared publications
Latest Publications
- 12 November 2026
- Published by Elsevier in Annals of Vascular Surgery
Success Rate and Factors Predictive of Redo Endothermal Ablation of Anterior Saphenous Veins (ASV)
- 12 November 2026
- Published by Elsevier in Annals of Vascular Surgery
Success Rate and Factors Predictive of Redo Endothermal Ablation of Anterior Saphenous Veins (ASV)
- Open Access
- 8 July 2026
- Published by Elsevier in Journal of Vascular Surgery: Venous and Lymphatic Disorders
- Vol. 14 (6) , 102576
Race/Ethnicity and Outcomes of Venous Ablation Procedures
- 8 July 2026
- Published by Elsevier in Journal of Vascular Surgery: Venous and Lymphatic Disorders
- Vol. 14 (6) , 102576
Open AccessRace/Ethnicity and Outcomes of Venous Ablation Procedures
- Open Access
- 23 October 2024
- Published by Elsevier in Journal of Vascular Surgery Cases, Innovations and Techniques
- Vol. 11 (1) , 101650
Endovascular repair and management of a ruptured inferior pancreaticoduodenal artery aneurysm: A case report and literature review
- 23 October 2024
- Published by Elsevier in Journal of Vascular Surgery Cases, Innovations and Techniques
- Vol. 11 (1) , 101650
Open AccessEndovascular repair and management of a ruptured inferior pancreaticoduodenal artery aneurysm: A case report and literature review
- Open Access
- 30 August 2024
- Published by Elsevier in JVS-Vascular Insights
- Vol. 2
A systematic review of telehealth and remote monitoring in vascular surgery
- 30 August 2024
- Published by Elsevier in JVS-Vascular Insights
- Vol. 2
Open AccessA systematic review of telehealth and remote monitoring in vascular surgery
- 26 August 2024
- Published by SAGE Publications in Vascular
- Vol. 33 (5) , 1007-1010
Venous stenting versus venous ablation
Background: The minimally invasive procedures of venous ablation and iliac vein stenting are evolving treatment options for venous insufficiency. Yet, there are no studies directly comparing the outcome of these procedures. We performed a survey on patients who had both procedures, to determine if either procedure helped more and if there is any other clinical factor related to the outcome. Method: We collected data between Jan 2012 and Feb 2019 from 726 patients who failed to improve swelling after conservative management. The patients underwent iliac vein stenting and vein ablations. We recorded patient assessment of the leg immediately after completion of both procedures. Follow-up was performed using in-person questionnaires by asking if improvement in lower extremity swelling occurred and if so, which procedure helped more. Results: Of the 726 patients who underwent endovenous closure and iliac vein stent placement, 254 (35%) were males. The average age of the patients was 70 (±13.7 SD, range 29–103) years. The presenting symptom (C of CEAP classification) of lower extremity limb venous disease was 34.8%, 44.6%, 5.6%, and 15% for C3–C6, respectively. Patients were asked about swelling, and they stated: swelling is better (605, 83.3%), swelling is not better (118, 16.3%), and not sure if there is any improvement in swelling (3, 0.4%). Patients stated the following completion of both procedures: both procedures equally helped (129, 18%), iliac vein stent superior (167, 23%), endovenous ablation superior (177, 24%), neither helped (112, 16%), and not sure which procedure helped more (141, 19%). After ANOVA, we concluded that older patients (average = 72.5 years) were more often not sure which procedure helped more ( p = .024), and younger patients (average = 68.4 years) stated that endovenous ablation helped more ( p = .014). There were no significant differences between the groups regarding gender ( p = .9), laterality ( p = .33), or presenting symptoms scores ( p = .9). There was no statistical relationship between the procedure that was performed first and the procedure that helped more ( p = 0.095). Conclusion: In this qualitative assessment, preliminary data suggest that the comparative role of iliac vein stent versus endovenous ablation warrants further study. The data were broadly distributed, and neither procedure was superior. In addition, 16% of the patients stated that neither procedure helped. The age of patients may also play a role in their procedure preferences and their subjective assessment for improvement.
- 26 August 2024
- Published by SAGE Publications in Vascular
- Vol. 33 (5) , 1007-1010
Venous stenting versus venous ablation
Background: The minimally invasive procedures of venous ablation and iliac vein stenting are evolving treatment options for venous insufficiency. Yet, there are no studies directly comparing the outcome of these procedures. We performed a survey on patients who had both procedures, to determine if either procedure helped more and if there is any other clinical factor related to the outcome. Method: We collected data between Jan 2012 and Feb 2019 from 726 patients who failed to improve swelling after conservative management. The patients underwent iliac vein stenting and vein ablations. We recorded patient assessment of the leg immediately after completion of both procedures. Follow-up was performed using in-person questionnaires by asking if improvement in lower extremity swelling occurred and if so, which procedure helped more. Results: Of the 726 patients who underwent endovenous closure and iliac vein stent placement, 254 (35%) were males. The average age of the patients was 70 (±13.7 SD, range 29–103) years. The presenting symptom (C of CEAP classification) of lower extremity limb venous disease was 34.8%, 44.6%, 5.6%, and 15% for C3–C6, respectively. Patients were asked about swelling, and they stated: swelling is better (605, 83.3%), swelling is not better (118, 16.3%), and not sure if there is any improvement in swelling (3, 0.4%). Patients stated the following completion of both procedures: both procedures equally helped (129, 18%), iliac vein stent superior (167, 23%), endovenous ablation superior (177, 24%), neither helped (112, 16%), and not sure which procedure helped more (141, 19%). After ANOVA, we concluded that older patients (average = 72.5 years) were more often not sure which procedure helped more ( p = .024), and younger patients (average = 68.4 years) stated that endovenous ablation helped more ( p = .014). There were no significant differences between the groups regarding gender ( p = .9), laterality ( p = .33), or presenting symptoms scores ( p = .9). There was no statistical relationship between the procedure that was performed first and the procedure that helped more ( p = 0.095). Conclusion: In this qualitative assessment, preliminary data suggest that the comparative role of iliac vein stent versus endovenous ablation warrants further study. The data were broadly distributed, and neither procedure was superior. In addition, 16% of the patients stated that neither procedure helped. The age of patients may also play a role in their procedure preferences and their subjective assessment for improvement.
- 20 August 2024
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 80 (3) , A21
Value and limitations of postoperative duplex scans after endovenous thermal ablation
- 20 August 2024
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 80 (3) , A21
Value and limitations of postoperative duplex scans after endovenous thermal ablation
- 9 August 2024
- Published by SAGE Publications in Vascular
- Vol. 33 (4) , 962-968
Contraindications to tissue plasminogen activator thrombolysis for acute lower extremity ischemia
Objective: Previous randomized prospective trials have demonstrated the effectiveness of transcatheter tissue plasminogen activator (tPA) thrombolysis in treating acute limb ischemia (ALI) compared to conventional surgery. These pivotal trials have also highlighted contraindications for these procedures. Given recent advancements in techniques and technology, our aim is to reassess the relevance of these contraindications in contemporary practice. Methods: A retrospective chart analysis was performed utilizing the inpatient medical records of consecutive individuals who underwent tPA treatment for acute limb ischemia (ALI) from September 2016 to April 2022. Inclusion criteria encompassed patients aged 18 and above displaying clinical symptoms and imaging evidence of ALI within 14 days. All patients received tPA with suction thrombectomy following the fast-track thrombolysis protocol. In cases where a persistent thrombus or stenosis was detected, catheter-directed thrombolysis was considered overnight, and patients underwent angiography and reassessment in the operating room subsequently. Results: Patients were classified into two groups based on the STILE trial’s established contraindications for endovascular treatment in acute limb ischemia (ALI). If a patient had any of these contraindications, they were placed in the contraindicated group. This resulted in 24 patients (32%) in the contraindicated group and 52 patients (68%) in the non-contraindicated group. No statistically significant demographic variations were observed between these groups. Contraindications in our study included uncontrolled hypertension (12/24, 50%), recent invasive procedures (7/27, 29%), history of cerebrovascular accident (CVA) within 6 months (3/24, 12%), and intracranial malformation/neoplasms (2/24, 8%). Three patients within the non-contraindicated group experienced bleeding complications: two with puncture site bleeds and one with nasal bleeding. In contrast, one patient in the contraindicated group had transient postoperative hematuria. There were no significant differences in bleeding complications observed between the two groups ( p = .771). Additionally, no amputations were observed within our population. Conclusions: In light of our study results and advancements in endovascular therapies, we can now safely and efficiently treat patients who were previously considered contraindicated for such treatments. It is essential to individualize treatments and carefully balance the risks and benefits of endovascular versus open surgical revascularization for these patients. Additionally, we believe that the nearly 30-year-old guidelines for endovascular therapies need to be revisited and updated to align with modern technology.
- 9 August 2024
- Published by SAGE Publications in Vascular
- Vol. 33 (4) , 962-968
Contraindications to tissue plasminogen activator thrombolysis for acute lower extremity ischemia
Objective: Previous randomized prospective trials have demonstrated the effectiveness of transcatheter tissue plasminogen activator (tPA) thrombolysis in treating acute limb ischemia (ALI) compared to conventional surgery. These pivotal trials have also highlighted contraindications for these procedures. Given recent advancements in techniques and technology, our aim is to reassess the relevance of these contraindications in contemporary practice. Methods: A retrospective chart analysis was performed utilizing the inpatient medical records of consecutive individuals who underwent tPA treatment for acute limb ischemia (ALI) from September 2016 to April 2022. Inclusion criteria encompassed patients aged 18 and above displaying clinical symptoms and imaging evidence of ALI within 14 days. All patients received tPA with suction thrombectomy following the fast-track thrombolysis protocol. In cases where a persistent thrombus or stenosis was detected, catheter-directed thrombolysis was considered overnight, and patients underwent angiography and reassessment in the operating room subsequently. Results: Patients were classified into two groups based on the STILE trial’s established contraindications for endovascular treatment in acute limb ischemia (ALI). If a patient had any of these contraindications, they were placed in the contraindicated group. This resulted in 24 patients (32%) in the contraindicated group and 52 patients (68%) in the non-contraindicated group. No statistically significant demographic variations were observed between these groups. Contraindications in our study included uncontrolled hypertension (12/24, 50%), recent invasive procedures (7/27, 29%), history of cerebrovascular accident (CVA) within 6 months (3/24, 12%), and intracranial malformation/neoplasms (2/24, 8%). Three patients within the non-contraindicated group experienced bleeding complications: two with puncture site bleeds and one with nasal bleeding. In contrast, one patient in the contraindicated group had transient postoperative hematuria. There were no significant differences in bleeding complications observed between the two groups ( p = .771). Additionally, no amputations were observed within our population. Conclusions: In light of our study results and advancements in endovascular therapies, we can now safely and efficiently treat patients who were previously considered contraindicated for such treatments. It is essential to individualize treatments and carefully balance the risks and benefits of endovascular versus open surgical revascularization for these patients. Additionally, we believe that the nearly 30-year-old guidelines for endovascular therapies need to be revisited and updated to align with modern technology.
- 18 July 2024
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 80 (2) , A15
A comparison of below-knee vs above-knee endovenous ablation of varicose veins
- 18 July 2024
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 80 (2) , A15
A comparison of below-knee vs above-knee endovenous ablation of varicose veins
- Open Access
- 15 May 2024
- Published by Elsevier in Journal of Vascular Surgery: Venous and Lymphatic Disorders
- Vol. 12 (5) , 101904
Indications, technical aspects, and outcomes of stent placement in chronic iliofemoral venous obstruction
- 15 May 2024
- Published by Elsevier in Journal of Vascular Surgery: Venous and Lymphatic Disorders
- Vol. 12 (5) , 101904
Open AccessIndications, technical aspects, and outcomes of stent placement in chronic iliofemoral venous obstruction
- Open Access
- 13 September 2023
- Published by Elsevier in Journal of Vascular Surgery: Venous and Lymphatic Disorders
- Vol. 12 (2) , 101679
A comparison of below-knee vs above-knee endovenous ablation of varicose veins
- 13 September 2023
- Published by Elsevier in Journal of Vascular Surgery: Venous and Lymphatic Disorders
- Vol. 12 (2) , 101679
Open AccessA comparison of below-knee vs above-knee endovenous ablation of varicose veins